Women Are Underrepresented in NSCLC Clinical Trials
Women are underrepresented in clinical trials of NSCLC treatment, a meta-analysis suggests.
All articles by Aaron Tallent
COVID-19 May Triple the Risk of Death During NSCLC Treatment
Patients with non-small cell lung cancer may have a 3-fold higher risk of death if they develop COVID-19, a study suggests.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...